文献速递认知障碍与痴呆

退伍军人轻型创伤性脑损伤的脑脊液β-淀粉样蛋白与Tau生物标志物变化

CSF β-Amyloid and Tau Biomarker Changes in Veterans With Mild Traumatic Brain Injury.
PubMed 文献 · Neurology · 2024-03-13

该横断面病例对照研究纳入51例爆炸相关轻型创伤性脑损伤(mTBI)退伍军人和85例无TBI退伍军人及平民,发现mTBI组脑脊液Aβ42和Aβ40随年龄增长而降低,但p-tau181和t-tau相对恒定,且mTBI组在较大年龄时认知表现更差。作者认为爆炸相关mTBI可能与阿尔茨海默病(AD)的病理过程有共同特征。

要点

  • 在50岁时,mTBI组脑脊液Aβ42和Aβ40均值分别比非mTBI组低154 pg/mL和1864 pg/mL。
  • mTBI组脑脊液p-tau181和t-tau随年龄保持相对恒定,而非mTBI组在较大年龄时趋于升高。
  • 在50岁时,mTBI组TMT-B时间均值多34秒,CVLT-II短延迟回忆均值低4.2分。

核心结论

  • 中年爆炸相关mTBI退伍军人的脑脊液Aβ水平降低,提示爆炸mTBI相关的慢性神经病理过程与预示AD起病的致病过程有共同特征,作者提出对这类退伍军人晚年可能发生痴呆性疾病的担忧。

研究设计与样本

  • 横断面病例对照研究,纳入来自2个研究来源的51例mTBI退伍军人和85例无mTBI退伍军人及平民。
  • 爆炸mTBI退伍军人至少有1次战区爆炸或爆炸/撞击合并mTBI,符合退伍军人事务部(VA)和国防部(DoD)的mTBI标准;非mTBI参与者无终生TBI史。
  • 所有参与者接受标准化临床和神经心理评估,并采集脑脊液,用MesoScale Discovery法测Aβ40和Aβ42,用INNOTEST ELISA测p-tau181和t-tau。

主要发现

  • mTBI组和非mTBI组平均(SD)年龄分别为34.0(10.1)岁和33.5(8.9)岁,除1人外(99%)均为男性。
  • mTBI组与非mTBI组脑脊液AD生物标志物差异随年龄变化,在较大年龄最明显(omnibus检验p≤0.08)。
  • 在50岁时,mTBI组脑脊液Aβ42和Aβ40均值分别比非mTBI组低154 [-12至319] pg/mL和1864 [610-3118] pg/mL。
  • mTBI组脑脊液p-tau181和t-tau均值随年龄保持相对恒定,而非mTBI组在较大年龄趋于升高。
  • mTBI组在较大年龄认知表现更差(omnibus p<0.08):在50岁时,TMT-B时间均值多34秒[10-58],CVLT-II短延迟回忆均值低4.2分[1.9-6.6];在较大年龄参与者中,较差的言语记忆和言语流畅性表现与较低脑脊液Aβ42相关(p≤0.05)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Moderate-to-severe traumatic brain injuries (TBI) have been reported to increase the risk of Alzheimer disease (AD). Whether mild TBI (mTBI) in veterans confers a similar increased risk of AD is less known. This study investigated early AD changes using CSF biomarkers in veterans with blast mTBI. METHODS: This was a cross-sectional case-control study of veterans with mTBI and non-mTBI veterans and civilians from 2 study sources. Blast-mTBI veterans had at least 1 war zone blast or combined blast/impact mTBI meeting Veterans Affairs (VA) and Department of Defense (DoD) criteria for mTBI. Non-mTBI participants had no lifetime history of TBI. All participants underwent standardized clinical and neuropsychological assessments and lumbar puncture for collection of the CSF. CSF biomarkers were measured using MesoScale Discovery assays for Aβ40 and Aβ42 and INNOTEST ELISAs for phosphorylated tau181 (p-tau181) and total tau (t-tau). RESULTS: Our sample comprised 51 participants with mTBI and 85 non-mTBI participants with mean (SD) ages 34.0 (10.1) and 33.5 years (8.9), respectively. All participants but 1 (99%) were male. Differences in CSF AD biomarkers between mTBI and non-mTBI groups were age dependent and most pronounced at older ages (omnibus test p ≤ 0.08). At age 50 years, the mTBI group had lower mean [95% CI] CSF Aβ42 and Aβ40 than the non-mTBI group by 154 [-12 to 319] and 1864 [610-3,118] pg/mL, respectively. By contrast, CSF p-tau181 and t-tau mean levels remained relatively constant with age in participants with mTBI, while tending to be higher at older ages for the non-mTBI group. The mTBI group also demonstrated poorer cognitive performance at older ages (omnibus p < 0.08): at age 50 years, the mean TMT-B time was higher by 34 seconds [10-58] and the mean CVLT-II short-delay recall was lower by 4.2 points [1.9-6.6]. Poorer verbal memory and verbal fluency performance were associated with lower CSF Aβ42 (p ≤ 0.05) in older participants. DISCUSSION: CSF Aβ levels decreased in middle-aged veterans with blast-related mTBI. These data suggest that chronic neuropathologic processes associated with blast mTBI share properties in common with pathogenic processes known to portend AD onset, thus raising concern that veterans with blast-related mTBI may develop a dementing disorder later in life.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Li G, Iliff J, Shofer J, et al. CSF β-Amyloid and Tau Biomarker Changes in Veterans With Mild Traumatic Brain Injury. Neurology. 2024. PMID: 38478804. doi:10.1212/WNL.0000000000209197

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。